Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
16.20
-0.28 (-1.70%)
Nov 17, 2026, 3:00 PM CST

SHA:600645 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,2311,0101,5281,5811,3931,196
Trading Asset Securities
597.47712.05----
Cash & Short-Term Investments
1,8291,7221,5281,5811,3931,196
Cash Growth
9.95%12.72%-3.38%13.48%16.54%12.76%
Accounts Receivable
599.86628.36644.94610.53575.98510.95
Other Receivables
10.643.271.9918.0928.4116.58
Receivables
610.5631.63646.93628.62604.39527.53
Inventory
238.67230.23232.19247.9248.09226.96
Prepaid Expenses
-00.512.386.482.98
Other Current Assets
61.5372.9248.8948.3657.6477.08
Total Current Assets
2,7402,6572,4562,5082,3102,030
Property, Plant & Equipment
564.72613.97688.71705.33765.54766.09
Long-Term Investments
798.21732.72736.84779.96804.31886.53
Goodwill
702.91702.91702.91702.91702.91702.91
Other Intangible Assets
111.4284.7100.45101.42111.73133.96
Long-Term Accounts Receivable
14.2119.2828.4737.455265.9
Long-Term Deferred Tax Assets
49.4950.4692.9581.856.0246.94
Long-Term Deferred Charges
110.43166.6165.22159.98148.88141.13
Other Long-Term Assets
256.97264.68277.08334333.2259.72
Total Assets
5,3485,2925,2495,4115,2855,033

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
90.1138.5547.3268.7656.8532.12
Accrued Expenses
59.06166.56170.15146.96134.91132.33
Current Portion of Long-Term Debt
---6.316.316.31
Current Portion of Leases
20.9921.3943.7523.3421.1916.69
Current Income Taxes Payable
34.4710.546.7117.9330.3824.97
Current Unearned Revenue
1,1221,1331,1341,1371,1121,078
Other Current Liabilities
92.0987.9685.481.29109.64105.56
Total Current Liabilities
1,4181,4581,4871,4821,4711,396
Long-Term Debt
---9.4615.7722.08
Long-Term Leases
43.6847.2868.488.3797.937.11
Long-Term Unearned Revenue
10.7910.089.5610.0210.9211.08
Long-Term Deferred Tax Liabilities
9.3510.5512.9523.1534.8734.7
Other Long-Term Liabilities
11.611.611.6---
Total Liabilities
1,4941,5371,5901,6131,6311,501

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
467.95467.95467.95467.95467.95467.95
Additional Paid-In Capital
3,3893,3893,3743,3773,3843,383
Retained Earnings
26.52-80.09-193.92-294.27-400.73-513.71
Treasury Stock
-200.03-200.03-200.03---
Comprehensive Income & Other
133.4129.8147.54133.31104.7125.98
Total Common Equity
3,8173,7073,5953,6843,5563,463
Minority Interest
37.148.2463.98114.5597.8569.31
Shareholders' Equity
3,8543,7553,6593,7993,6543,533
Total Liabilities & Equity
5,3485,2925,2495,4115,2855,033

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
64.6768.67112.15127.48141.1882.2
Net Cash (Debt)
1,7641,6531,4161,4541,2521,113
Net Cash Growth
10.90%16.80%-2.62%16.09%12.46%11.14%
Net Cash Per Share
3.793.633.103.142.662.37
Filing Date Shares Outstanding
455.9455.9455.9467.95467.95467.95
Total Common Shares Outstanding
455.9455.9455.9467.95467.95467.95
Working Capital
1,3211,199968.931,027838.53634.56
Book Value Per Share
8.378.137.897.877.607.40
Tangible Book Value
3,0032,9192,7922,8802,7412,627
Tangible Book Value Per Share
6.596.406.126.155.865.61
Land
-3.463.543.493.433.14
Buildings
-546.03546.68482.6497.7558.38
Machinery
-696.34700.82690.88653.02623.86
Construction In Progress
-5.6510.5418.9823.2320.5